3
Announcements
Trials
Browse
Landscape
Status
Unknown
2
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Malnutrition
4
Esophageal Neoplasms
3
Head and Neck Neoplasms
2
Weight Loss
1
Stomach Neoplasms
1
Postoperative Complications
1
Pancreatic Neoplasms
1
Nutritional Support
1
Neoplasms, Plasma Cell
1
Neoplasms
1
Nasopharyngeal Carcinoma
1
Muscular Atrophy
1
Lymphoma
1
Hyperphagia
1
Gastrointestinal Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Digestive System Neoplasms
1
Deglutition Disorders
1
Critical Illness
1
Child Nutrition Disorders
1
Cachexia
1
Interventions
Gemcitabine
358
Fluorouracil
94
Oxaliplatin
81
Capecitabine
74
130-nm albumin-bound paclitaxel
71
Albumin-Bound Paclitaxel
70
Radiotherapy
67
Leucovorin
58
Irinotecan
49
Erlotinib Hydrochloride
47
Cisplatin
44
Bevacizumab
31
pembrolizumab
30
Radiosurgery
30
Docetaxel
26
Taxes
24
Nivolumab
24
Cetuximab
24
Pancreaticoduodenectomy
20
Drug Therapy
17
folfirinox
16
Cyclophosphamide
16
Radiation
15
Ipilimumab
13
Endoscopic Ultrasound-Guided Fine Needle Aspiration
13
Surgical Procedures, Operative
12
Sorafenib
12
Paclitaxel
12
Neoadjuvant Therapy
12
irinotecan sucrosofate
11
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Pancreatic Neoplasms
×
Enteral Nutrition
×
Clear all
NCT02400398
2020-08-11
PanCax
Cedars-Sinai Medical Center
Completed
30 enrolled